01358 PW MEDTECH
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 10.89X | Oper Margin | 20.0% |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | 11.5% |
| Total Debt/Equity | 0.6% | Return on Equity | 2.4% |
| Price/Book | 0.36X | Return on Assets | 1.8% |
| (HKD 1.080) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 105.05 | 160.35 | 168.84 | 118.89 | 904.02 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -34.5 | -5.0 | +42.0 | -86.9 | +20.6 |
| Earnings Per Share (HKD) | 0.07 | 0.104 | 0.108 | 0.076 | 0.576 |
| Earnings Per Share Growth (%) | -33.1 | -3.6 | +42.0 | -86.8 | +20.6 |
| Dividend Per Share (HKD) | 0.064 | 0.098 | 0.099 | No dividend | No dividend |
| P/E* (X) | 15.54 | 10.39 | 10.02 | 14.23 | 1.87 |
| Yield (%) | 5.93 | 9.07 | 9.12 | N/A | N/A |
| Dividend Share (%) | 92.09 | 94.32 | 91.37 | N/A | N/A |
| Book NAV (HKD) | 2.984 | 2.841 | 2.847 | 2.825 | 2.956 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 823.505 | 768.903 | +7.1 | 675.084 |
| Operating Result | 164.994 | 229.86 | -28.2 | 238.206 |
| Profit Before Taxation | 164.994 | 229.753 | -28.2 | 231.067 |
| Taxation | 29.741 | 37.231 | -20.1 | 26.044 |
| Profit /( Loss) After Taxation | 135.253 | 192.522 | -29.7 | 205.023 |
| Minority Interests | 40.879 | 41.742 | -2.1 | 51.839 |
| Net Profit | 94.374 | 150.78 | -37.4 | 153.184 |
| Earnings Per Share () | 0.0695 | 0.1039 | -33.1 | 0.1078 |
| Dividend Per Share () | 0.0640 | 0.0980 | -34.7 | 0.0985 |
| Announcement Date | 2026-03-27 | 2025-03-28 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
